BLT 0.00% 2.6¢ benitec biopharma limited

Gradalis's phase 2 results due early next year. By then we...

  1. 169 Posts.
    Gradalis's phase 2 results due early next year. By then we should get more information from Standford's preclinical trials with the pain program. If we get good news from Stanford plus licensing from Gradalis, I wonder what the sp will be like.
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.